Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience
暂无分享,去创建一个
L. Andritsos | D. Benson | Y. Efebera | S. Devine | S. Jaglowski | Junan Li | S. Vasu | S. Penza | B. William | J. Roddy | Filiz Yucebay | M. Puto | Christina M. Matthews